½ÃÀ庸°í¼­
»óǰÄÚµå
1621857

±Û·çÅ©·Î³ë¶ôÅæ ½ÃÀå ¼ºÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Glucuronolactone Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 235 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ±Û·çÅ©·Î³ë¶ôÅæ ½ÃÀåÀº 2023³â 4¾ï 3,430¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇß°í, 2024-2032³â°£ CAGRÀº 5.7%¸¦ ³Ñ¾î¼³ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Û·çÄí·Î³ë¶ôÅæÀº ¿µ¾ç º¸ÃæÁ¦ ¹× ±â´É¼º À½·á¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖÀ¸¸ç, ¿¡³ÊÁö ÁõÁø, ÀÎÁö ´É·Â °­È­ ¹× ÇØµ¶À» Áö¿øÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ±× °¡Ä¡¸¦ ÀÎÁ¤¹Þ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ õ¿¬ ¹× Ŭ¸° ¶óº§ Á¦Ç°À¸·Î À̵¿Çϰí Á¦Á¶¾÷üµéÀÌ ±Û·çÄí·Î³ë¶ôÅæÀ» »õ·Î¿î Á¦Çü¿¡ Æ÷ÇÔ½ÃŰ·Á´Â µ¿±â¸¦ ºÎ¿©Çϸ鼭 ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇÇÆ®´Ï½º ¹× À£ºù Æ®·»µåÀÇ Àαâ Áõ°¡¿Í ±â´É¼º ¼ººÐ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ºÆ÷Ã÷ ¿µ¾ç ½ÃÀå¿¡¼­ ±Û·çÄí·Î³ë¶ôÅæÀÇ ¼ºÀå¿¡ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. °Ç°­ ÁöÇâÀû Á¦Ç°¿¡ ´ëÇÑ ÀÌ·¯ÇÑ °ü½É Áõ°¡´Â ÇâÈÄ ¸î ³âµ¿¾È ±Û·çÄí·Î³ë¶ôÅæÀÇ Àû¿ë ¹üÀ§¸¦ È®ÀåÇÏ°í ´Ù¾çÇÑ °Ç°­ Á᫐ ºÎ¹®¿¡¼­ º¸´Ù Çõ½ÅÀûÀÎ Á¦Ç° °³¹ßÀÇ ±æÀ» ¿­¾îÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2023³â ºÐ¸» ÇüÅÂÀÇ ±Û·çÄí·Î³ë¶ôÅæÀº 2¾ï 8,380¸¸ ´Þ·¯ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2032³â±îÁö ¿¬Æò±Õ 5.8%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÐ¸» ºÎ¹®Àº °Ç°­ º¸Á¶ ½Äǰ ¹× ±âŸ °Ç°­ Á¦Ç°¿¡ ½±°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â ´ÙÀç´Ù´ÉÇÔ ¶§¹®¿¡ ƯÈ÷ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÐ¸» ±Û·çÄí·Î³ë¶ôÅæÀº ÀúÀå ¾ÈÁ¤¼º°ú ¼ö¸íÀÌ ¿ì¼öÇÏ¿© Á¦Á¶¾÷ü°¡ ´Ù¾çÇÑ ¿ëµµ¿¡ ºñ¿ë È¿À²ÀûÀÎ ¼ººÐÀ¸·Î ±âÀçÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇüÅÂÀÇ Àαâ´Â ¿¡³ÊÁö ´ë»ç¿Í ÇØµ¶¿¡ ÀÖ¾î ±Û·çÅ©·Î³ë¶ôÅæÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀڵ鿡°Ô Å« È£ÀÀÀ» ¾ò°í ÀÖ½À´Ï´Ù. ±â´É¼º À½·á °ü·Ã ½ÃÀå ºÎ¹®µµ °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2023³â ½ÃÀå ±Ô¸ð´Â 1¾ï 6,570¸¸ ´Þ·¯ ÀÌ»óÀ¸·Î 2032³â±îÁö 5.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¡³ÊÁö ÁõÁø Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä´Â Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» Ãß±¸ÇÏ´Â ¼ÒºñÀÚ Æ®·»µå¿Í ÀÏÄ¡Çϸç, ±Û·çÅ©·Î³ë¶ôÅæÀº Áö±¸·Â Çâ»ó°ú ÇǷΠȸº¹¿¡ µµ¿òÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

»õ·Î¿î À½·á ºê·£µå°¡ µîÀåÇÔ¿¡ µû¶ó ±Û·çÅ©·Î³ë¶ôÅæ°ú °°Àº ±â´É¼º ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä´Â ƯÈ÷ ÀþÀº ÃþÀÌ ½ÅüÀû, Á¤½ÅÀû ¼º´ÉÀ» Áö¿øÇÏ´Â Á¦Ç°À» ã°Ô µÇ¸é¼­ È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À¯Åë Ãø¸é¿¡¼­´Â ¿Â¶óÀÎ ¼Ò¸Å°¡ 2023³â 1¾ï 5,320¸¸ ´Þ·¯ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϸç 2032³â±îÁö 5.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀüÀÚ»ó°Å·¡ÀÇ Æí¸®¼ºÀ¸·Î ÀÎÇØ ¼ÒºñÀÚ´Â ´Ù¾çÇÑ ±Û·çÅ©·Î³ë¶ôÅæ Á¦Ç°¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ°í °¡°Ý ºñ±³¿Í °í°´ ¸®ºäµµ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. °¡°Ý ºñ±³ ¹× °í°´ ¸®ºäµµ ¾òÀ» ¼ö ÀÖ¾î ¼±È£µµ°¡ ³ôÀº ±¸¸Å ¹æ¹ýÀÔ´Ï´Ù. ¹Ì±¹ ½ÃÀåµµ È£Á¶¸¦ º¸À̸ç 2023³â 8,570¸¸ ´Þ·¯, 2032³â±îÁö 5.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº À£ºù ¹× ÇÇÆ®´Ï½º Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ³ôÀº °ü½É, źźÇÑ À¯Åë¸Á, ¹Ì±¹ ¼ÒºñÀÚÀÇ ÃëÇâ¿¡ ¸ÂÃá Çõ½Å¿¡ ±âÀÎÇÕ´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024³â-2032³â
½ÃÀÛ ±Ý¾× 4¾ï 3,430¸¸ ´Þ·¯
¿¹»ó ±Ý¾× 7¾ï 1,190¸¸ ´Þ·¯
CAGR 5.7%

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀο¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ
    • ÀÌÀÍ·ü ºÐ¼®
    • º¯Çõ
    • ÇâÈÄ Àü¸Á
    • Á¦Á¶¾÷ü
    • À¯Åë¾÷ü
  • °ø±Þ¾÷ü »óȲ
  • ÀÌÀÍ·ü ºÐ¼®
  • ÁÖ¿ä ´º½º
  • ±ÔÁ¦ »óȲ
  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿¡³ÊÁö µå¸µÅ©¿Í ±â´É¼º ½Äǰ ¼ö¿ä Áõ°¡
      • ½ÄÀ̺¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚ °Ç°­ ÀǽÄÀÇ °í¾ç
      • ½ºÆ÷Ã÷ ¿µ¾ç°ú ÆÛÆ÷¸Õ½º Çâ»ó Á¦Ç° Àα⠻ó½Â
      • Á¦Ç° ¹èÇÕ°ú Àü´Þ ½Ã½ºÅÛ Çõ½Å
    • »ê¾÷ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • ´ëü ¿¡³ÊÁö Áõ°­ ¼ººÐ°úÀÇ °æÀï Áõ°¡
      • ±×¸£Å©·Î³ë¶óũſ¿¡ °ü·ÃµÈ ÀáÀçÀûÀÎ °Ç°­ ¿ì·Á¿Í ºÎÀÛ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Çüź°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÐ¸»
  • ĸ½¶/Á¤Á¦

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¿¡³ÊÁö µå¸µÅ©
  • º¸ÃæÁ¦¿Í ½ÄÀ̺¸ÃæÁ¦
  • ÀǾàǰ
  • È­Àåǰ ¹× ÆÛ½º³ÎÄɾî
  • ½Äǰ ¹× À½·á ÷°¡¹°
  • ±âŸ

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : À¯Åë ä³Îº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¿Â¶óÀÎ ¼Ò¸Å
  • ¾à±¹ ¹× µå·°½ºÅä¾î
  • ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
  • °Ç°­ Àü¹®Á¡
  • ±âŸ

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦9Àå ±â¾÷ °³¿ä

  • Aadhunik Industries
  • Anhui Fubore Pharmaceutical & Chemical
  • Anmol Chemicals
  • Foodchem International
  • FUJIFILM Wako Pure Chemical Corporation
  • Hubei Yitai Pharmaceutical
  • Jungbunzlauer
  • Merck
  • Muby Chemicals
  • Shandong Fuyuan Bio-Tech
LSH 25.01.10

The Global Glucuronolactone Market reached a valuation of USD 434.3 million in 2023 and is projected to grow at a CAGR exceeding 5.7% from 2024 to 2032. As demand rises across various industries, glucuronolactone has found broad application in dietary supplements and functional beverages, where it is valued for its ability to boost energy, enhance cognitive performance, and support detoxification. Market growth is further fueled by shifting consumer preferences towards natural and clean-label products, motivating manufacturers to integrate glucuronolactone into new formulations. The increasing popularity of fitness and wellness trends, combined with a greater awareness of functional ingredients, has contributed significantly to its growth in the sports nutrition market. This heightened interest in health-oriented products is expected to expand the scope of glucuronolactone applications over the coming years, paving the way for more innovative product development in various health-focused sectors.

In 2023, the powder form of glucuronolactone dominated with a market share of USD 283.8 million, anticipated to grow at a 5.8% CAGR from 2024 to 2032. The powder segment is particularly favored for its versatility, which allows easy integration into dietary supplements and other health products. In addition, powdered glucuronolactone offers better shelf stability and longevity, providing manufacturers with a cost-effective ingredient for a range of applications. The popularity of this form is driven by increasing awareness of glucuronolactone's role in energy metabolism and detoxification, which resonates strongly with health-conscious consumers. The market segment linked to functional beverages also performed robustly, holding a value of over USD 165.7 million in 2023, with an expected CAGR of 5.8% through 2032. The demand for energy-boosting products aligns with consumer trends toward active lifestyles, where glucuronolactone is incorporated for its capacity to enhance endurance and combat fatigue.

As new beverage brands emerge, the demand for functional ingredients like glucuronolactone is set to grow, particularly as younger demographics seek out products that support physical and mental performance. In terms of distribution, online retail captured a leading share of USD 153.2 million in 2023 and is forecasted to grow at 5.9% CAGR until 2032. The convenience of e-commerce has made it a preferred purchasing method, allowing consumers easy access to a variety of glucuronolactone products, along with price comparisons and customer reviews. The U.S. market also demonstrated strong performance, with a valuation of USD 85.7 million in 2023 and an anticipated 5.7% CAGR through 2032. This growth is driven by high consumer interest in wellness and fitness products, alongside a robust distribution network and innovations tailored to U.S. consumer preferences.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$434.3 Million
Forecast Value$711.9 Million
CAGR5.7%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Increasing demand for energy drinks and functional foods
      • 3.6.1.2 Growing health awareness among consumers regarding dietary supplements
      • 3.6.1.3 Rising popularity of sports nutrition and performance-enhancing products
      • 3.6.1.4 Innovation in product formulations and delivery systems
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Increasing competition from alternative energy-boosting ingredients
      • 3.6.2.2 Potential health concerns and side effects associated with glucuronolactone
  • 3.7 Growth potential analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Form, 2021-2032 (USD Million) (Units)

  • 5.1 Key trends
  • 5.2 Powder
  • 5.3 Capsule/tablets

Chapter 6 Market Estimates & Forecast, By Application, 2021-2032 (USD Million) (Units)

  • 6.1 Key trends
  • 6.2 Energy drinks
  • 6.3 Supplements & nutraceuticals
  • 6.4 Pharmaceuticals
  • 6.5 Cosmetics & personal care
  • 6.6 Food & beverage additives
  • 6.7 Others

Chapter 7 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Million) (Units)

  • 7.1 Key trends
  • 7.2 Online retail
  • 7.3 Pharmacies/drugstores
  • 7.4 Supermarkets/hypermarkets
  • 7.5 Specialty health stores
  • 7.6 Others

Chapter 8 Market Estimates & Forecast, By Region, 2021-2032 (USD Million) (Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Aadhunik Industries
  • 9.2 Anhui Fubore Pharmaceutical & Chemical
  • 9.3 Anmol Chemicals
  • 9.4 Foodchem International
  • 9.5 FUJIFILM Wako Pure Chemical Corporation
  • 9.6 Hubei Yitai Pharmaceutical
  • 9.7 Jungbunzlauer
  • 9.8 Merck
  • 9.9 Muby Chemicals
  • 9.10 Shandong Fuyuan Bio-Tech
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦